Insurance coverage lookup

See which local health plans provide coverage for ORIAHNN

Select your state and county below to explore insurance coverage in your area.

92%†

of commercially insured patients now have access to ORIAHNN

As of 1/22/2021.

Coverage varies by channel: Commercial: 92%;

Managed Medicaid: 65%;  Fee-for-Service Medicaid: 70%.

State

    County

      Oriahnn® Complete Access Specialists are an in-person and over-the-phone resource with expertise in options to consider based on each patient’s unique insurance coverage situation

      For support, call 1-800-ORIAHNN (1-800-674-2466)

      Coverage requirements and benefit designs vary by payer and may change over time. Please consult with payers directly for the most current reimbursement policies. The health plans and/or pharmacy benefit managers listed here have not endorsed and are not affiliated with this material.

       

      *The ORIAHNN free trial provides a single 28-day trial supply of ORIAHNN at no cost to new patients residing in the United States with a valid prescription for an FDA-approved indication of ORIAHNN and who enroll in Oriahnn Complete. The trial is intended solely to allow new patients not currently taking ORIAHNN to determine with their healthcare provider whether ORIAHNN is right for them. There is no obligation to continue use of ORIAHNN after the trial has concluded and this program does not guarantee insurance coverage. Eligible patients are limited to one 28-day trial supply and may not re-enroll. The ORIAHNN trial supply will be dispensed only through an AbbVie-authorized pharmacy to the patient’s home address and may not be sold or further distributed. No claims for payment may be submitted to any third party insurance plan for product dispensed by program. AbbVie reserves the right to change or discontinue the trial at any time without notice. The trial is not health insurance and is not a discount, coupon, rebate or financial assistance program. Limitations may apply.

      Formulary definitions: Access means the product is covered and not NDC blocked. A plan is considered covered if it has one of the following access statuses: Preferred Brand Tier, Non Preferred Brand Tier, Non Preferred Specialty Tier, Covered (FFS), Approved Until Review, or Approved Until Review with PA to Label.

      §ORIAHNN formulary coverage data has been provided using MAT as the main source, with some changes made by AbbVie. 2019 MAT lives are being used.